Stocks and Investing Stocks and Investing
Thu, July 22, 2021
Wed, July 21, 2021

Joseph Schwartz Maintained (ASND) at Buy with Decreased Target to $178 on, Jul 21st, 2021


Published on 2024-10-27 17:16:07 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $181 to $178 on, Jul 21st, 2021.

Joseph has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, March 30th, 2021


These are the ratings of the 4 analyists that currently disagree with Joseph


  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $197 on, Monday, June 14th, 2021
  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $189 on, Monday, June 14th, 2021
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, June 1st, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $178 on, Friday, May 28th, 2021
Contributing Sources